Your browser doesn't support javascript.
loading
Neoantigen-based EpiGVAX vaccine initiates antitumor immunity in colorectal cancer.
Kim, Victoria M; Pan, Xingyi; Soares, Kevin C; Azad, Nilofer S; Ahuja, Nita; Gamper, Christopher J; Blair, Alex B; Muth, Stephen; Ding, Ding; Ladle, Brian H; Zheng, Lei.
Affiliation
  • Kim VM; The Sidney Kimmel Comprehensive Cancer Center.
  • Pan X; Department of Oncology, and.
  • Soares KC; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Azad NS; The Sidney Kimmel Comprehensive Cancer Center.
  • Ahuja N; Department of Oncology, and.
  • Gamper CJ; The Sidney Kimmel Comprehensive Cancer Center.
  • Blair AB; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Muth S; The Sidney Kimmel Comprehensive Cancer Center.
  • Ding D; Department of Oncology, and.
  • Ladle BH; The Sidney Kimmel Comprehensive Cancer Center.
  • Zheng L; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
JCI Insight ; 5(9)2020 05 07.
Article in En | MEDLINE | ID: mdl-32376802
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Cancer Vaccines / Enzyme Inhibitors / Decitabine / Immunotherapy / Antimetabolites, Antineoplastic Limits: Animals Language: En Journal: JCI Insight Year: 2020 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Cancer Vaccines / Enzyme Inhibitors / Decitabine / Immunotherapy / Antimetabolites, Antineoplastic Limits: Animals Language: En Journal: JCI Insight Year: 2020 Document type: Article Country of publication: United States